Pasar al contenido principal

IMPLICACIONES FISIOPATOLOGICAS DE LOS MECANISMOS DE RECAMBIO Y PROLIFERACION, BENIGNA Y MALIGNA, DE LAS CELULAS FOLICULARES TIROIDEAS HUMANAS Y DE GLANDULAS ENDOCRINAS

BFU2016-76973-R

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos I+D+i Retos de Investigación
Año convocatoria 2016
Plan Estatal 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDADE DE SANTIAGO DE COMPOSTELA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Mitochondrial cristae-remodeling protein OPA1 in POMC neurons couples Ca2+ homeostasis with adipose tissue lipolysis

  • Gómez-Valadés, Alicia
  • Pozo, Macarena
  • Varela, Luis
  • Boutagouga Boudjadja, Mehdi
  • Ramírez, Sara
  • Chivite, Iñigo
  • Eyre, Elena
  • Haddad-Tóvolli, Roberta
  • Obri, Arnaud
  • Milà-Guasch, María
  • Altirriba, Jordi
  • Schneeberger, Marc
  • Imbernón, Mónica
  • Garcia-Rendueles, Ángela R.
  • Gama-Perez, Pau
  • Rojo-Ruiz, Jonathan
  • Rácz, Bence
  • Alonso, María Teresa
  • Gomis, Ramón
  • Zorzano, Antonio
  • D’Agostino, Giuseppe
  • Álvarez, Clara V.
  • Nogueiras, Rubén
  • García-Rovés, Pablo M.
  • Horvath, Tamas L.
  • Claret, Marc
© 2021 The Authors., Appropriate cristae remodeling is a determinant of mitochondrial function and bioenergetics and thus represents a crucial process for cellular metabolic adaptations. Here, we show that mitochondrial cristae architecture and expression of the master cristae-remodeling protein OPA1 in proopiomelanocortin (POMC) neurons, which are key metabolic sensors implicated in energy balance control, is affected by fluctuations in nutrient availability. Genetic inactivation of OPA1 in POMC neurons causes dramatic alterations in cristae topology, mitochondrial Ca2+ handling, reduction in alpha-melanocyte stimulating hormone (α-MSH) in target areas, hyperphagia, and attenuated white adipose tissue (WAT) lipolysis resulting in obesity. Pharmacological blockade of mitochondrial Ca2+ influx restores α-MSH and the lipolytic program, while improving the metabolic defects of mutant mice. Chemogenetic manipulation of POMC neurons confirms a role in lipolysis control. Our results unveil a novel axis that connects OPA1 in POMC neurons with mitochondrial cristae, Ca2+ homeostasis, and WAT lipolysis in the regulation of energy balance., This work was supported by Agencia Estatal de Investigación y Fondo Social Europeo, Proyecto BFU2016-76973-R FEDER (C.V.A.); AG052005, AG052986, AG051459, DK111178 from NIH and NKFI-KKP-126998 from Hungarian National Research, Development and Innovation Office (T.L.H.); MR/P009824/2 from Medical Research Council UK (G.D.); and Ayudas Fundación BBVA a Investigadores y Creadores Culturales (2015), European Research Council (ERC) under the European Union’s Horizon 2020 Research And Innovation Program (grant agreement 725004) and CERCA Programme/Generalitat de Catalunya (M.C.). A.O. is supported by a Miguel Servet contract (CP19/00083) from Instituto de Salud Carlos III and co-financed by FEDER.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

dsRNAi-mediated silencing of PIAS2beta specifically kills anaplastic carcinomas by mitotic catastrophe

  • Rodrigues, Joana S.
  • Chenlo, Miguel
  • Bravo, Susana B.
  • Pérez-Romero, Sihara
  • Suarez-Fariña, Maria
  • Sobrino, Tomás
  • Sanz-Pamplona, Rebeca
  • González-Prieto, Román
  • Blanco Freire, Manuel Narciso
  • Nogueiras, Ruben
  • López, Miguel
  • Fugazzola, Laura
  • Cameselle-Teijeiro, José Manuel
  • Álvarez, Clara V.
The E3 SUMO ligase PIAS2 is expressed at high levels in differentiated papillary thyroid carcinomas but at low levels in anaplastic thyroid carcinomas (ATC), an undifferentiated cancer with high mortality. We show here that depletion of the PIAS2 beta isoform with a transcribed double-stranded RNA-directed RNA interference (PIAS2b-dsRNAi) specifically inhibits growth of ATC cell lines and patient primary cultures in vitro and of orthotopic patient-derived xenografts (oPDX) in vivo. Critically, PIAS2b-dsRNAi does not affect growth of normal or non-anaplastic thyroid tumor cultures (differentiated carcinoma, benign lesions) or cell lines. PIAS2b-dsRNAi also has an anti-cancer effect on other anaplastic human cancers (pancreas, lung, and gastric). Mechanistically, PIAS2b is required for proper mitotic spindle and centrosome assembly, and it is a dosage-sensitive protein in ATC. PIAS2b depletion promotes mitotic catastrophe at prophase. High-throughput proteomics reveals the proteasome (PSMC5) and spindle cytoskeleton (TUBB3) to be direct targets of PIAS2b SUMOylation at mitotic initiation. These results identify PIAS2b-dsRNAi as a promising therapy for ATC and other aggressive anaplastic carcinomas., This work was supported by Agencia Estatal de Investigación (AEI, Spain), co-funded by the European Union, projects’ codes BFU2013-46109-R, BFU2016-76973-R, PID2019-110437RB-I00, PDC2021-121621-I00 and PID2022-140149OB-I00 to C.V.A. This work has received financial support from the Xunta de Galicia (Centro singular de investigación de Galicia accreditation 2019-2022) and the European Union (European Regional Development Fund - ERDF). J.M.C.-T. is supported by grant no. ISCIII-PI23/00722, and PI19/01316 from Instituto de Salud Carlos III, State Research Agency (Spain), co-funded by the European Union. L.F. is funded by Italian Ministry of Health - Ricerca Corrente. T.S. is recipient of a research contract from the Miguel Servet Program from the Instituto de Salud Carlos III, Ref. CPII17/00027, co-funded by the European Union., Peer reviewed